Traditional or decentralized–is it a binary decision?
As the industry changes and evolves, we are continually asking what’s practical, what’s patient-centric, and what’s acceptable to regulators. Research has shown that every sponsor is looking for faster trial execution, reduced patient burden, and greater patient engagement/retention. Decentralization delivers key benefits, whether it be the whole trial or elements of the trial—but is the path of the future defined?
To succeed, our industry needs a combination of top-down trial design with bottom-up patient preference. The smartest industry leaders are prioritizing virtual and hybrid methods instead of one-track rigor, appreciating the nuance between decentralized and centralized.
Watch back on this fireside chat in which we explore the path forward beyond the pandemic—uncovering how remote trial conduct enables patient access, diversity, speed, retention, and experience. Discover how the alignment of language, terminology, and the process is a reliable path to approval.
Fill out the form to access the on-demand recording!
Speakers
